Hartland & Co »

Telomir Pharmaceuticals shares owned by Hartland & Co

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Hartland & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $17k 13k 1.39

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs Put Option (Principal) (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Largecap Divd (DLN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Hartland & Co

Top funds holding Telomir Pharmaceuticals

Vanguard Group
BlackRock
Millennium Management
Geode Capital Management
Raymond James Financial
UBS Group
State Street Corporation
Bank of New York Mellon
Suncoast Equity Management
Northern Trust
Morgan Stanley
Advisor Group Holdings
Resources Investment Advisors
Goldman Sachs Group
Praetorian Wealth Management

View all funds holding Telomir Pharmaceuticals